Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Phase I results reported for Bristol-Myers Squibb candidate for autoimmune diseases

Nov. 14, 2017

Five Prime, GlaxoSmithKline present novel neighbor of punc e11 polypeptides

Nov. 13, 2017

Novel retinoid RORgammaT receptor modulators identified at Janssen

Nov. 10, 2017

Synermore compares safety and pharmacokinetics of SYN-060 to Humira

Nov. 9, 2017

FDA grants orphan drug designation to arimoclomol for inclusion body myositis

Nov. 8, 2017

FDA awards rare pediatric disease designation to ArQule's miransertib

Nov. 2, 2017

First patient enrolled in phase III trial of piclidenoson in rheumatoid arthritis

Oct. 31, 2017

Study confirms nonsedative effects of Neurana's skeletal muscle relaxant tolperisone

Oct. 27, 2017

Regentis Biomaterials identifies new conjugates for bone disorders

Oct. 27, 2017

FDA grants fast track designation to MIV-711 for treatment of osteoarthritis

Oct. 25, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
More than two to tango: multispecifics at ESMO TAT
BioWorld Science
Multispecifics took center stage at this year’s ESMO TAT, emerging as one of the hottest trends in oncology research. Unlike traditional small-molecule drugs or...